STO-CSCO Joint Symposium 2017

Continuing to build on the vibrant partnership of STO and CSCO, this symposium will be featured during the 20th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) from September 26 – 30, 2017.

Translated Articles

《肿瘤学家》精选论文
Read translations of selected articles targeting practice issues relevant to Chinese clinicians.

Browse All Topics

The Oncologist in China

《肿瘤学家》中国项目概览
Download a 2-page pdf overview of The Oncologist’s Clinical Trial Results section information.

Video Library

视频库
Watch the latest presentations from the STO First Advisory Council: LUNG CANCER: A Grand Challenge for Public Health & Education.

Past Meetings

Welcome to 'The Oncologist' in China

Recent Translated Articles from The Oncologist

Volume 22, Number 2, February 2017


Gastrointestinal Cancer

KRAS突变阴性胰腺导管腺癌中的致癌性ALK融合和RRAS突变
An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation‐Negative Pancreatic Ductal Adenocarcinoma
Yoko Shimada, Takashi Kohno, Hideki Ueno, Yoshinori Ino, Hideyuki Hayashi, Takashi Nakaoku, Yasunari Sakamoto, Shunsuke Kondo, Chigusa Morizane, Kazuaki Shimada, Takuji Okusaka, Nobuyoshi Hiraoka
The Oncologist 2017; 22:158-164; first published on February 6, 2017; doi:10.1634/theoncologist.2016-0194

Lung Cancer

以无进展生存期替代总生存期作为恶性间皮瘤研究终点的方法验证:癌症和白血病工作组B与中北部癌症治疗组(联合)试验分析
Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
Xiaofei Wang, Xiaoyi Wang, Lydia Hodgson, Stephen L. George, Daniel J. Sargent, Nate R. Foster, Apar Kishor Ganti, Thomas E. Stinchcombe, Jeffrey Crawford, Robert Kratzke, Alex A. Adjei, Hedy L. Kindler, Everett E. Vokes, Herbert Pang
The Oncologist 2017; 22:189-198; first published on February 10, 2017; doi:10.1634/theoncologist.2016-0121

Volume 22, Number 1, January 2017


Global Health and Cancer

中国实体瘤患者的临终化疗
Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies
Jin Sheng, Ya‐Xiong Zhang, Xiao‐Bo He, Wen‐Feng Fang, Yun‐Peng Yang, Gui‐Nan Lin, Xuan Wu, Ning Li, Jing Zhang, Lin‐Zhu Zhai, Yuan‐Yuan Zhao, Yan Huang, Ning‐Ning Zhou, Hong‐Yun Zhao, Li Zhang
The Oncologist 2017; 22:53-60; first published on October 27, 2016; doi:10.1634/theoncologist.2016-0013

对全身治疗反应不一显示出非小细胞肺癌患者可能存在遗传异质性且生存期不佳
Mixed Responses to Systemic Therapy Revealed Potential Genetic Heterogeneity and Poor Survival in Patients with Non‐Small Cell Lung Cancer
Zhong‐Yi Dong, Hao‐Ran Zhai, Qing‐Yi Hou, Jian Su, Si‐Yang Liu, Hong‐Hong Yan, Yang‐Si Li, Zhi‐Yong Chen, Wen‐Zhao Zhong, Yi‐Long Wu
The Oncologist 2017; 22:61-69; doi:10.1634/theoncologist.2016-0150

No front page content has been created yet.

 

The Oncologist and the Society for Translational Oncology (STO) partner with the Chinese Society of Clinical Oncology (中国抗癌协会临床肿瘤学协作专业委员会, CSCO) and the CSCO Foundation (中国临床肿瘤学会基金会) on educational initiatives that address critical health and cancer care issues in China. These efforts serve to foster communication between Chinese physicians and other leaders in oncology practice throughout the world.